Table 2 Responses to question 20 [Do you apply RECIST 1.1 criteria for response evaluation in clinical practice (not in clinical trials)?]. Results have been dichotomized according to geographic regions (Europe vs other countries), working experience (< 10 years vs > 10 years), and type of institutions (research facilities—university hospital and research institute vs other institutes). A p-value < 0.05 was considered statistically significant
Never | Yes, always | Yes, but only in specific cases | |
|---|---|---|---|
Total no. of responses | 74/286 (25.9%) | 119/286 (41.6%) | 93/286 (32.5%) |
Europe | 54/197 (27.4%) | 75/197 (38.1%) | 68/197 (34.5%) |
Other | 20/89 (22.5%) | 44/89 (49.4%) | 25/89 (28.1%) |
p-value | 0.18 | 0.08 | 0.32 |
Unexperienced | 37/115 (32.2%) | 42/115 (36.5%) | 36/115 (31.3%) |
Experienced | 37/171 (21.7%) | 77/171 (45%) | 57/171 (33.3%) |
p-value | 0.06 | 0.13 | 0.72 |
Research facilities | 48/148 (32.4%) | 50/148 (33.8%) | 50/148 (33.8%) |
Other | 26/138 (18.8%) | 69/138 (50%) | 43/138 (31.2%) |
p-value | 0.01 | 0.006 | 0.58 |